BNP prefers Sun Pharma and JB Chemicals in the pharma space and while it likes Apollo Hospitals Enterprise and Metropolis Healthcare Ltd in the healthcare services.
Brokerage firms expect Sun Pharma to come out with a healthy set of numbers in Q3FY24, aided by specialty portfolio and domestic brand formulation, which will help offset US generic pressures.
Holding Deloitte Haskins & Sells LLP and CJ Goswami & Associates, the secretarial auditor of Sun Pharmaceutical Industries Ltd (Sun Pharma), responsible for not reporting related party transactions of Sun Pharma with its sole distributor and promoter entity Aditya Medisales Ltd, the registrar of companies (RoC) in Gujarat has slapped a penalty of Rs1.50 lakh each on the audit firm and secretarial auditor of the company.